Chief Technical Officer
Protagonist Therapeutics
Newark, California, United States
Dr. Masjedizadeh has served as Executive Vice President & Chief Technical Officer since June 2021 and has served as EVP/VP of Pharmaceutical Development from 2017-2021. Prior to joining Protagonist, he was VP of Technical Operations at Principia Biopharma (2012-2017), focusing on CMC development of Reversible Covalent BTK inhibitors. He worked at Roche Pharmaceuticals both in Palo Alto, CA and Nutley, NJ from 1991 to 2012 with increasing responsibilities leading to his promotion to Director of Drug Substance & Supply. Dr. Masjedizadeh received his Ph.D. from University of California at Santa Barbara and conducted his post-doctoral work also at UCSB.
Disclosure information not submitted.
Monday, July 14, 2025
4:00 PM - 4:30 PM EDT
